Annual Net Income
-$18.85 M
-$3.58 M-23.42%
31 December 2023
Summary:
CNS Pharmaceuticals annual net profit is currently -$18.85 million, with the most recent change of -$3.58 million (-23.42%) on 31 December 2023. During the last 3 years, it has fallen by -$9.39 million (-99.32%). CNSP annual net income is now -386.21% below its all-time high of -$3.88 million, reached on 31 December 2019.CNSP Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$5.61 M
-$3.08 M-121.51%
30 September 2024
Summary:
CNS Pharmaceuticals quarterly net profit is currently -$5.61 million, with the most recent change of -$3.08 million (-121.51%) on 30 September 2024. Over the past year, it has dropped by -$1.08 million (-23.95%). CNSP quarterly net income is now -2801.60% below its all-time high of -$193.20 thousand, reached on 30 September 2018.CNSP Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$17.06 M
-$1.08 M-6.78%
30 September 2024
Summary:
CNS Pharmaceuticals TTM net profit is currently -$17.06 million, with the most recent change of -$1.08 million (-6.78%) on 30 September 2024. Over the past year, it has increased by +$1.56 million (+8.36%). CNSP TTM net income is now -6523.96% below its all-time high of -$257.50 thousand, reached on 30 June 2018.CNSP TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNSP Net Income Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -23.4% | -23.9% | +8.4% |
3 y3 years | -99.3% | -47.0% | -19.7% |
5 y5 years | -155.0% | -693.3% | -113.7% |
CNSP Net Income High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -99.3% | at low | -121.5% | at low | -27.4% | +9.5% |
5 y | 5 years | -386.2% | at low | -693.3% | at low | -339.9% | +9.5% |
alltime | all time | -386.2% | at low | -2801.6% | +15.5% | -6524.0% | +9.5% |
CNS Pharmaceuticals Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$5.61 M(+121.5%) | -$17.06 M(+6.8%) |
June 2024 | - | -$2.53 M(-28.6%) | -$15.97 M(-8.5%) |
Mar 2024 | - | -$3.54 M(-34.1%) | -$17.46 M(-7.4%) |
Dec 2023 | -$18.85 M(+23.4%) | -$5.38 M(+18.8%) | -$18.85 M(+1.3%) |
Sept 2023 | - | -$4.52 M(+12.5%) | -$18.61 M(+6.3%) |
June 2023 | - | -$4.02 M(-18.5%) | -$17.51 M(+2.7%) |
Mar 2023 | - | -$4.93 M(-4.0%) | -$17.05 M(+11.7%) |
Dec 2022 | -$15.27 M(+5.4%) | -$5.14 M(+50.2%) | -$15.27 M(+14.1%) |
Sept 2022 | - | -$3.42 M(-4.1%) | -$13.39 M(-2.9%) |
June 2022 | - | -$3.57 M(+13.1%) | -$13.79 M(-1.8%) |
Mar 2022 | - | -$3.15 M(-3.1%) | -$14.03 M(-3.2%) |
Dec 2021 | -$14.50 M | -$3.25 M(-14.7%) | -$14.50 M(+1.7%) |
Sept 2021 | - | -$3.81 M(+0.0%) | -$14.25 M(+14.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2021 | - | -$3.81 M(+5.5%) | -$12.44 M(+12.1%) |
Mar 2021 | - | -$3.61 M(+20.3%) | -$11.10 M(+17.4%) |
Dec 2020 | -$9.46 M(+143.9%) | -$3.00 M(+49.4%) | -$9.46 M(+5.3%) |
Sept 2020 | - | -$2.01 M(-18.7%) | -$8.98 M(+17.0%) |
June 2020 | - | -$2.47 M(+25.7%) | -$7.68 M(+36.2%) |
Mar 2020 | - | -$1.97 M(-22.1%) | -$5.63 M(+45.3%) |
Dec 2019 | -$3.88 M(-47.5%) | -$2.53 M(+257.6%) | -$3.88 M(-51.4%) |
Sept 2019 | - | -$706.70 K(+63.7%) | -$7.98 M(+6.9%) |
June 2019 | - | -$431.70 K(+104.1%) | -$7.47 M(+2.4%) |
Mar 2019 | - | -$211.50 K(-96.8%) | -$7.29 M(+3.0%) |
Dec 2018 | -$7.39 M | -$6.63 M(+3332.5%) | -$7.08 M(+1471.4%) |
Sept 2018 | - | -$193.20 K(-25.0%) | -$450.70 K(+75.0%) |
June 2018 | - | -$257.50 K | -$257.50 K |
FAQ
- What is CNS Pharmaceuticals annual net profit?
- What is the all time high annual net income for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals annual net income year-on-year change?
- What is CNS Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals quarterly net income year-on-year change?
- What is CNS Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for CNS Pharmaceuticals?
- What is CNS Pharmaceuticals TTM net income year-on-year change?
What is CNS Pharmaceuticals annual net profit?
The current annual net income of CNSP is -$18.85 M
What is the all time high annual net income for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high annual net profit is -$3.88 M
What is CNS Pharmaceuticals annual net income year-on-year change?
Over the past year, CNSP annual net profit has changed by -$3.58 M (-23.42%)
What is CNS Pharmaceuticals quarterly net profit?
The current quarterly net income of CNSP is -$5.61 M
What is the all time high quarterly net income for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high quarterly net profit is -$193.20 K
What is CNS Pharmaceuticals quarterly net income year-on-year change?
Over the past year, CNSP quarterly net profit has changed by -$1.08 M (-23.95%)
What is CNS Pharmaceuticals TTM net profit?
The current TTM net income of CNSP is -$17.06 M
What is the all time high TTM net income for CNS Pharmaceuticals?
CNS Pharmaceuticals all-time high TTM net profit is -$257.50 K
What is CNS Pharmaceuticals TTM net income year-on-year change?
Over the past year, CNSP TTM net profit has changed by +$1.56 M (+8.36%)